Revenue, last quarter
$299.7M
+4.6% vs same quarter last year
Net income
$28.3M
−25.9% vs same quarter last year
EPS, diluted
$0.18
−25% vs same quarter last year
Operating cash flow
$73.1M
+165% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $1.2B | $181.9M |
| FY25 | $1.2B | $73.4M |
| FY24 | $1.2B | $168.1M |
| FY23 | $1.1B | $285.3M |
| FY22 | $1.1B | $272.1M |
| FY21 | $931M | $140.4M |
| FY20 | $738.7M | $229.3M |
| FY19 | $714M | $96.1M |
| FY18 | $643M | $126.2M |
| FY17 | $563M | $76.1M |
| FY16 | $499M | $104.5M |
| FY15 | $452.2M | $107.7M |
| FY14 | $357.8M | $110.9M |
| FY13 | $310.6M | $112.6M |
| FY12 | $314.6M | $112.3M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 65.8% | 20.7% | 15% |
| FY25 | 64.8% | 8.4% | 6% |
| FY24 | 66.4% | 17.8% | 14.5% |
| FY23 | 67.7% | 26.3% | 25.1% |
| FY22 | 68.4% | 26.8% | 24.6% |
| FY21 | 68% | 25.5% | 15.1% |
| FY20 | 65.4% | 21.3% | 31% |
| FY19 | 66.3% | 20.5% | 13.5% |
| FY18 | 67.2% | 21.2% | 19.6% |
| FY17 | 66.5% | 21.4% | 13.5% |
| FY16 | 67.5% | 30.2% | 20.9% |
| FY15 | 67.9% | 32.5% | 23.8% |
| FY14 | 70.3% | 44.7% | 31% |
| FY13 | 74.4% | 0.1% | 36.2% |
| FY12 | 75% | 52.8% | 35.7% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | $263.2M |
| FY25 | $256.6M |
| FY24 | $236.1M |
| FY23 | $216.1M |
| FY22 | $280.4M |
| FY21 | $307.9M |
| FY20 | $153.5M |
| FY19 | $156.2M |
| FY18 | $149.4M |
| FY17 | $128.5M |
| FY16 | $127.3M |
| FY15 | $119.5M |
| FY14 | $122.9M |
| FY13 | $101.1M |
| FY12 | $120.7M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY26 | $49.9M | $41.7M |
| FY25 | $50.4M | $275.7M |
| FY24 | $50.4M | $80M |
| FY23 | $50.3M | $19.6M |
| FY22 | $50.2M | $161M |
| FY21 | $49.6M | $43.2M |
| FY20 | $48.9M | $50.1M |
| FY19 | $48.4M | $15.4M |
| FY18 | $48M | $0 |
| FY17 | $47.3M | - |
| FY16 | $47.6M | - |
| FY15 | $47.1M | $0 |
| FY14 | $45.4M | $0 |
| FY13 | $43.5M | $1.8M |
| FY12 | $41M | $23.6M |
- Bio-Techne
- Healthcare median
Show the numbers
| Year | Bio-Techne | Healthcare median |
|---|---|---|
| FY26 | 15% | −11.1% |
| FY25 | 6% | −30.6% |
| FY24 | 14.5% | −47% |
| FY23 | 25.1% | −58% |
| FY22 | 24.6% | −80.4% |
| FY21 | 15.1% | −71.9% |
| FY20 | 31% | −62.2% |
| FY19 | 13.5% | −46.3% |
| FY18 | 19.6% | −49.6% |
| FY17 | 13.5% | −45.9% |
| FY16 | 20.9% | −36% |
| FY15 | 23.8% | −38.4% |
| FY14 | 31% | −35.5% |
| FY13 | 36.2% | −37.1% |
| FY12 | 35.7% | −29.1% |